Chase Coleman III
Tiger Global Management
Chase Coleman III Lam Research Corp stake
total: 436
Tiger Global Management LRCX trades
- Total transactions:
- 10
- New positions:
- 1
- Added:
- 6
- Reduced:
- 3
- Held since:
- 2023 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Chase Coleman III holds 3,163,495 Lam Research Corp (LRCX) shares with a market value of roughly $1.37B accounting for 5.72% of the overall portfolio. To date, the estimated cost basis is nearly $118.18 for "buy" trades and estimated average "sell" price is $279.75. Tiger Global Management first purchased LRCX in 2023 Q1, initially acquiring 100,228 shares. Since the initial investment in Lam Research Corp (LRCX), Tiger Global Management has made 9 more transactions.
When did Chase Coleman III buy Lam Research Corp (LRCX)?
Chase Coleman III first invested in Lam Research Corp (LRCX) in 2023 Q1 at the reported quarter-end price of $530.12 per share.
What's the cost basis of Tiger Global Management's LRCX stake?
The estimated cost basis for Lam Research Corp (LRCX) stake is around $118.18 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $118.18
- Weighted AVG sell price:
- $279.74
Chase Coleman III's historical trades in Lam Research Corp
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
5.72%
|
3,163,495
|
$433.33
|
$1,370,837,288
|
-18.89% (-736,944)
|
-1.4%
|
|
2025 Q4
|
2.25%
|
3,900,439
|
$171.18
|
$667,677,148
|
-25.85% (-1,359,889)
|
-0.72%
|
|
2025 Q2
|
1.50%
|
5,260,328
|
$97.34
|
$512,040,328
|
+18.89% (+835,628)
|
+0.24%
|
|
2025 Q1
|
1.21%
|
4,424,700
|
$72.70
|
$321,675,690
|
+11.80% (+467,000)
|
+0.13%
|
|
2024 Q4
|
1.08%
|
3,957,700
|
$72.23
|
$285,864,671
|
+1,020.58% (+3,604,517)
|
+0.98%
|
|
2024 Q1
|
1.88%
|
353,183
|
$971.57
|
$343,142,007
|
-12.36% (-49,800)
|
-0.34%
|
|
2023 Q4
|
2.25%
|
402,983
|
$783.26
|
$315,640,465
|
+8.90% (+32,945)
|
+0.18%
|
|
2023 Q3
|
1.71%
|
370,038
|
$626.77
|
$231,928,717
|
+8.35% (+28,510)
|
+0.13%
|
|
2023 Q2
|
1.83%
|
341,528
|
$642.86
|
$219,554,690
|
+240.75% (+241,300)
|
+1.3%
|
|
2023 Q1
|
0.48%
|
100,228
|
$530.12
|
$53,132,867
|
new
|
+0.48%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.